Most quantitative peptide work fails through ordinary dilution arithmetic rather than through chemistry, and the error modes are predictable.
Key Takeaways
- Each step in a serial dilution carries its own error, and the errors compound.
- Pipetting DMSO and glycerol-containing solutions by air displacement is inaccurate unless the pipette is calibrated for the liquid.
- Where results depend on concentration, verify by an independent method such as UV absorbance or amino acid analysis.
Serial dilution drift
Each step in a serial dilution carries its own error, and the errors compound. Preparing an intermediate stock once and diluting from it is generally more accurate than a long serial series.
Surface adsorption losses
Peptides adsorb to plastic and glass, and the loss is proportionally largest at low concentration. Using low-binding consumables and avoiding very dilute intermediate stocks materially improves accuracy.
For related mechanism work, see buffer preparation peptides.
Viscous and volatile solvents
Pipetting DMSO and glycerol-containing solutions by air displacement is inaccurate unless the pipette is calibrated for the liquid. Reverse pipetting and pre-wetting the tip improve accuracy substantially.
Unit confusion
Confusing mass with molar concentration, or micrograms with microlitres of a stock, is the most common single error. Writing the target in molar units and checking the arithmetic twice prevents most occurrences.
Verification
Where results depend on concentration, verify by an independent method such as UV absorbance or amino acid analysis. A nominal concentration derived from weighing is an assumption, not a measurement.
Experimental Conditions and Practical Setup
A single intermediate stock is prepared and used for all dilutions rather than running a long serial series, because each serial step carries its own error. Viscous solvents are handled with reverse pipetting and pre-wetted tips, and the final concentration is verified analytically where the result depends on it.
Error sources ranked by impact
| Source | Magnitude | Control |
|---|---|---|
| Unit or calculation error | Can be orders of magnitude | Write targets in molar units, check twice |
| Serial dilution drift | Compounds with each step | Use a single intermediate stock |
| Surface adsorption | Large at low concentration | Low-binding consumables |
| Viscous solvent pipetting | Several percent | Reverse pipetting, pre-wet tips |
Practical Notes for the Bench
- Prepare a single intermediate stock rather than long serial dilutions.
- Use reverse pipetting and pre-wetting for viscous solvents.
- Verify concentration independently when results depend on it.
Frequently Asked Questions
Why do my dilutions not match expected activity?
Most often because of compounding error in serial dilutions or surface adsorption at low concentration.
Is pipetting DMSO accurate with standard tips?
Not without correction; use reverse pipetting and pre-wetting, or calibrate for the specific liquid.
Should I trust the nominal concentration?
Treat it as an assumption and verify independently when the result depends on it.
Why do replicate dilutions sometimes disagree?
Usually because of adsorption at low concentration or because a viscous solvent was pipetted with an air-displacement technique calibrated for water.
Related Reading
- buffer preparation peptides
- peptide aliquoting workflow
- evaluating peptide research
- nasal peptide delivery
- BPC-157 mechanism of action
References & Further Reading
- Bratcher PE et al. Characterization and prevention of the adsorption of surfactant protein D to polypropylene. PLoS One. 2013. PubMed 24039953
- Ranade AV et al. Characterization of Sample Loss Caused by Competitive Adsorption of Proteins in Vials Using Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis. Langmuir. 2019. PubMed 30813715
- Peptide literature search on PubMed
- Full-text archive at PubMed Central
- FDA guidance documents on peptide drug products
This article summarises published research practice for laboratory professionals. It is not a guide to human use, and no claim of therapeutic benefit is made or implied.
Reviewed by James Okoro, BSc, Laboratory Operations & Documentation.